Fenwal, Inc. clinical trials
Acquired by Fresenius Kabi, 2012 · source ↗
The registry lists 3 studies whose lead sponsor is Fenwal, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2025.
Before and after it joined Fresenius Kabi
- First submitted before Fenwal, Inc. became part of Fresenius Kabi
- 1
- First submitted after Fenwal, Inc. became part of Fresenius Kabi
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Fenwal, Inc.3 studies
Something wrong with this grouping? Tell us on the Fresenius Kabi page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Fresenius Kabi studies →
- Evaluation of the Aurora Xi New Nomogram Software 2.0CompletedNCT06122935Not applicable
Sponsor listed in the registry: Fenwal, Inc. · First submitted after Fenwal, Inc. became part of Fresenius Kabi
- Evaluation of the AMICUS RBCx System in Sickle Cell PatientsCompletedNCT02372877Not applicable
Sponsor listed in the registry: Fenwal, Inc. · First submitted after Fenwal, Inc. became part of Fresenius Kabi
- Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS DeviceCompletedNCT01210716Phase 3
Sponsor listed in the registry: Fenwal, Inc. · First submitted before Fenwal, Inc. became part of Fresenius Kabi